Myfortic Versus Azathioprine in Systemic Lupus Erythematosus
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to explore the use of myfortic ® in patients with active lupus
erythematosus. Similar drugs in this class are increasingly used in organ transplantation and
in autoimmune diseases. With the established safety profile of myfortic ® in
allo-transplantation and the already existing data of mycophenolate mofetil in autoimmune
diseases, this study should help to demonstrate the beneficial effect of myfortic ® on lupus
activity. The aim of the study will be to show a decreased disease activity with myfortic ®
compared to standard maintenance therapy with azathioprine.